查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018580

胃腸病門診手術中心市場：按服務、適應症、醫療級別、患者群體、應用、最終用戶和所有權分類——2026-2032年全球市場預測

Gastroenterology Ambulatory Surgery Center Market by Services, Indication, Level of Care, Patient Demographic, Application, End-User, Ownership - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年胃腸病門診手術中心市場價值為 76 億美元，預計到 2026 年將成長至 82.1 億美元，複合年成長率為 8.59%，到 2032 年將達到 135.5 億美元。

主要市場統計數據
基準年 2025 76億美元
預計年份：2026年 82.1億美元
預測年份 2032 135.5億美元
複合年成長率 (%) 8.59%

本書對胃腸病學門診手術中心進行了簡明扼要的介紹，重點關注臨床範圍、運營多樣性以及以患者為中心的服務的演變。

在臨床創新、患者對便利性的需求以及對更高效診療路徑的需要的推動下，胃腸病學門診手術中心（ASC）模式正在重塑診斷和治療程序的提供方式。近年來，內視鏡技術、微創手術技術和手術全期管理的進步，擴大了可在門診安全開展的手術範圍。因此，專業的胃腸病學機構正在發展成為高容量中心，提供膠囊內視鏡、大腸鏡檢查以及各種上消化道和下消化道手術，同時保持高效的後續觀察和日間手術服務。

臨床創新、保險報銷變化和人力資源動態的融合如何加速門診胃腸病護理的轉型。

由於技術創新、醫療服務體系的重塑以及人力資源環境的演變，目前門診胃腸外科中心正經歷變革性的轉變。高解析度影像、膠囊內視鏡和新一代內視鏡技術提高了診斷準確性，而內視鏡黏膜切除術、黏膜下剝離術和精細切除術等先進治療方案則拓展了門診治療的選擇範圍。同時，隨著手術全期期方案和麻醉技術的進步縮短了恢復時間，包括腹腔鏡胃腸手術和括約肌切開術、疝氣修補術等在內的微創手術也逐漸轉向門診模式。

評估 2025 年關稅趨勢對門診胃腸道護理服務和資本投資計劃的累積營運和採購影響。

2025年關稅和貿易政策的轉變為胃腸病門診手術中心（ASC）的供應鏈、資本投資規劃和籌資策略帶來了新的考量。許多診斷和治療設備、一次性用品以及內視鏡配件都依賴全球製造網路。進口關稅的增加和貿易緊張局勢可能導致採購成本上升和前置作業時間。對於那些專注於資本密集型設備升級（例如購買先進內視鏡和微創手術系統）的醫療機構而言，關稅帶來的成本壓力迫使其重新評估升級週期、租賃與購買的選擇以及總擁有成本（TCO）。

綜合細分分析揭示了服務類型、適應症、護理層級和所有權結構如何影響消化器官系統門診手術中心的策略重點。

透過精細的細分分析，我們得以了解胃腸病門診手術中心整體情況中臨床機會與營運重點的交會點。按服務項目分析，診斷能力涵蓋膠囊內視鏡、大腸鏡、食道測壓、乙狀結腸鏡和上消化道內視鏡等，支援高通量工作流程，從而實現早期發現和高效轉診。外科服務包括減重手術、膽囊切除術、結直腸手術、腹股溝疝氣修補術以及日益普及的腹腔鏡胃腸手術。同時，內視鏡黏膜切除術、內視鏡黏膜下剝離術、痔瘡結紮術、息肉切除術和硬化療法等治療服務正在建構完善的門診診療路徑，從而減少住院需求。

影響美洲、歐洲、中東和非洲以及亞太地區部署、贖回和能力建設的區域趨勢和戰略考量

區域趨勢對全球的營運模式、先進手術的普及程度以及監管合規要求都產生了顯著影響。在美洲，成熟的報銷系統和向門診治療的強勁成長推動了以內視鏡手術為重點的門診手術中心（ASC）和獨立手術中心的快速發展，尤其注重結直腸癌篩檢計畫和以效率為導向的日間手術流程。北美醫療機構通常利用整合採購和現有的認證框架來規範品質並降低單次手術成本，而參與企業市場的機構則在探索與打包支付方案和保險公司網路建立合作關係。

醫療設備製造商、門診手術中心營運商和綜合醫療保健系統之間的競爭與合作策略正在推動創新和業務規模化。

門診胃腸病服務的競爭格局由醫療設備製造商、技術創新者、門診手術中心營運商以及透過臨床差異化和夥伴關係實現規模化的綜合醫療保健系統共同塑造。醫療設備和耗材供應商優先考慮一次性產品，這些產品需具備耐用性、影像清晰度和經濟高效的處理能力，同時降低交叉感染的風險。將硬體與分析功能、遠端監控和服務等級協定 (SLA) 結合的供應商，為門診手術中心營運商提供最佳化運作和手術效率的工具。

為高階主管提供具體的策略指南，以加強臨床能力、實現價值鏈多元化，並在門診胃腸病護理中創造價值。

門診胃腸病學領域的領導者應採取積極主動、多管齊下的策略，在實現臨床和經濟價值的同時，降低風險。首先，應優先投資於能夠提供高臨床療效和手術效率的診斷和治療內視鏡設備，並輔以系統化的培訓項目，以提升臨床醫生的能力。其次，應透過與多家供應商簽訂合約、建立區域製造夥伴關係以及參與聯合採購協議，實現採購管道多元化，從而降低供應衝擊和關稅相關成本波動帶來的風險。第三，應透過擴展日間手術方案、加強術前遠距遠端醫療評估以及最佳化後續觀察路徑，改善服務配置和處理能力，在不影響安全性的前提下縮短住院時間。

我們將採用高度透明的混合方法調查方法，結合一手訪談、第二手資料和情境分析，以獲得對 ASC（腹部外科中心）的實用見解。

本執行摘要是基於一項整合了第一手和第二手研究途徑的研究，以確保其嚴謹性和相關性。第一手資料包括對臨床醫生、門診手術中心管理人員、供應鏈專家和保險公司進行的結構化訪談，從而獲得有關手術流程、採購重點和報銷互動方面的定性見解。第二手研究涵蓋同行評審的臨床文獻、監管指南、醫療設備性能文件和公開文件，以支援對臨床趨勢和技術能力的分析。

總結了策略協調、臨床投資和供應鏈韌性對於消化器官系統手術中心長期成功至關重要的原因。

門診胃腸病中心處於臨床創新、營運最佳化和不斷變化的患者期​​望的交匯點，既蘊含著巨大的機遇，也面臨著嚴峻的營運挑戰。診斷和治療性內視鏡技術的進步以及手術全期護理的改善，使得更多手術能夠轉移到日間護理和後續觀察模式，從而提高了醫療服務的可及性並降低了整體醫療成本。然而，諸如費用波動、供應鏈依賴以及區域報銷機制差異等外部壓力，要求制定策略應對措施，在投資臨床能力的同時，兼顧嚴謹的營運和採購慣例。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：胃腸病門診手術中心市場：依服務類型分類

  • 診斷服務
    • 膠囊內視鏡
    • 大腸鏡檢查
    • 食道壓力測量
    • 乙狀結腸鏡檢查
    • 上消化道內視鏡檢查
  • 手術治療
    • 減重手術
    • 膽囊切除術
    • 大腸直腸/直腸手術
    • 腹股溝疝氣修補手術
    • 腹腔鏡胃腸手術
    • 括約肌切開術
  • 治療服務
    • 內視鏡黏膜切除術
    • 內視鏡黏膜下剝離術
    • 痔瘡結紮術
    • 息肉切除術
    • 硬化療法

第9章：胃腸病門診手術中心市場：依適應症分類

  • 大腸直腸癌篩檢
  • 胃腸道感染疾病
  • 發炎性腸道疾病
  • 肝硬化

第10章：依醫療級別分類的門診胃腸外科中心市場

  • 觀察
  • 門診手術

第11章：門診胃腸外科中心病患市場細分

  • 成人
  • 老年人
  • 兒童

第12章：胃腸病門診手術中心市場：依應用領域分類

  • 診斷測試
  • 內視鏡檢查
  • 治療性介入

第13章：胃腸病門診手術中心市場：依最終用戶分類

  • 診所/私人診所
  • 醫院
  • 獨立門診手術中心

第14章：胃腸病門診手術中心市場：依所有權類型分類

  • 公司所有權
  • 獨立的
  • 醫院附屬機構

第15章：胃腸病門診手術中心市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章：胃腸病門診手術中心市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章：胃腸病門診手術中心市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國胃腸病門診手術中心市場

第19章：中國消化內科門診手術中心市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alabama Digestive Health Endoscopy Center（AL）
  • Alfa Surgery Center, LLC
  • Athens Gastroenterology Center
  • Baptist Health South Florida, Inc.
  • Covenant Physician Partners
  • Envision Healthcare Corporation
  • Gastro Health LLC
  • Gastroenterology Associates Endoscopy Center
  • GE HealthCare Technologies Inc.
  • Gulf Coast Endoscopy Center
  • HCA Healthcare, Inc.
  • Inova McLean Ambulatory Surgery Center
  • Jupiter Outpatient Surgery Center, LLC
  • Liberty Endoscopy Center
  • OHIO GASTROENTEROLOGY & LIVER INSTITUTE and GASTRO HEALTH
  • Ohio Gastroenterology Group Inc.
  • Ontario Advanced Surgery Center
  • Regent Surgical
  • SCA Health
  • Shelby Ambulatory Surgery
  • SOUTH BROWARD ENDOSCOPY, LLC
  • Tenet Healthcare Corporation
  • The Outpatient Center of Boynton Beach
  • United Digestive
  • Universal Health Services, Inc.
Product Code: MRR-B9334AD6C1A9

The Gastroenterology Ambulatory Surgery Center Market was valued at USD 7.60 billion in 2025 and is projected to grow to USD 8.21 billion in 2026, with a CAGR of 8.59%, reaching USD 13.55 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.60 billion
Estimated Year [2026] USD 8.21 billion
Forecast Year [2032] USD 13.55 billion
CAGR (%) 8.59%

An incisive introduction to ambulatory gastroenterology centers highlighting clinical scope operational diversity and patient-centric service evolution

The ambulatory surgery center (ASC) model for gastroenterology is reshaping how diagnostic and therapeutic procedures are delivered, driven by clinical innovation, patient preference for convenience, and efficiencies in care pathways. In recent years, advances in endoscopic technology, minimally invasive surgical techniques, and perioperative management have expanded the range of procedures safely performed in outpatient settings. As a result, facilities that concentrate on gastroenterology are evolving into high-capacity hubs that deliver capsule endoscopy, colonoscopy, and a wide spectrum of upper and lower gastrointestinal procedures while maintaining streamlined observation and same-day surgery services.

Operational structures vary across clinics and physicians' offices, hospital-affiliated units, and independent ASCs, while ownership models range from corporation-owned platforms to freestanding and hospital-aligned centers. Patient demographics span pediatric care through adult and geriatric populations, requiring tailored clinical protocols, recovery pathways, and perioperative support. Moreover, the application landscape incorporates diagnostic tests, endoscopy procedures, and therapeutic interventions such as endoscopic mucosal resection and submucosal dissection, which are increasingly performed outside traditional inpatient settings. This convergence of capabilities and patient-centered design positions gastroenterology ASCs as a pivotal part of modern care delivery, delivering high-value, lower-cost alternatives that emphasize throughput, safety, and patient experience.

How converging clinical innovations reimbursement shifts and workforce dynamics are accelerating outpatient gastroenterology care transformation

The landscape of gastroenterology ambulatory surgery centers is undergoing transformative shifts driven by technological innovation, care delivery redesign, and workforce evolution. High-resolution imaging, capsule endoscopy, and next-generation endoscopes are improving diagnostic yield while advanced therapeutic options such as endoscopic mucosal resection, submucosal dissection, and refined polypectomy techniques are expanding the therapeutic scope possible in same-day settings. Concurrently, minimally invasive surgical approaches including laparoscopic gastrointestinal surgeries and targeted procedures like sphincterotomy and hernia repair are migrating toward outpatient platforms as perioperative protocols and anesthesia techniques reduce recovery times.

Payment reforms and value-based contracting are incentivizing site-of-care optimization, accelerating the transfer of lower-acuity, high-volume procedures from inpatient hospitals to independent ASCs and clinic-based settings. Telehealth and remote preoperative assessment tools are enhancing throughput and reducing no-show rates, while integrated electronic health records and procedural analytics enable continuous quality improvement and real-time case management. Workforce dynamics-particularly the need for advanced endoscopy-trained clinicians, perioperative nurses, and specialized technicians-are prompting investments in training and retention programs. Lastly, patient expectations for convenience, transparency, and rapid access have intensified competition, compelling providers to differentiate through care coordination, same-day surgery pathways, and enhanced recovery protocols that collectively shift the balance of care toward ambulatory environments.

Assessing the cumulative operational and procurement consequences of 2025 tariff dynamics on ambulatory gastroenterology services and capital planning

Policy shifts related to tariffs and trade in 2025 have introduced a new set of considerations for supply chains, capital planning, and procurement strategies for gastroenterology ASCs. Many diagnostic and therapeutic devices, disposables, and endoscopy accessories rely on global manufacturing networks; increases in import duties or trade frictions can raise acquisition costs and introduce variability into lead times. For providers focused on capital-intensive upgrades such as purchasing advanced endoscopes or minimally invasive surgical systems, tariff-induced cost pressures require re-evaluation of replacement cycles, leasing versus purchasing decisions, and total cost of ownership assessments.

The cumulative effect extends beyond device cost to inventory management and contracting behavior. Facilities are responding by diversifying supplier portfolios, negotiating fixed-price multi-year contracts, and exploring regional manufacturing partnerships to mitigate exposure. Independent ASCs, with typically narrower purchasing scale compared to large hospital systems, may seek group purchasing arrangements or strategic alliances to restore bargaining parity. At the same time, tariff-related price increases can accelerate consolidation as organizations pursue operational scale to absorb cost shocks. Reimbursement frameworks that do not keep pace with rising input costs will place margin pressure on lower-reimbursed procedures performed in ambulatory settings, prompting leadership to optimize case mix, enhance coding and documentation practices, and pursue higher-value therapeutic interventions that align with payer priorities. Ultimately, a strategic and differentiated supply-chain response combined with proactive financial modeling will be essential for maintaining service continuity and preserving investment in innovation under tariff uncertainty.

Integrated segmentation analysis revealing how service types indications levels of care and ownership models shape strategic priorities in gastroenterology ASCs

A nuanced segmentation view illuminates where clinical opportunity and operational focus intersect across the gastroenterology ASC landscape. When analyzed by services, diagnostic capabilities extend from capsule endoscopy and colonoscopy to esophageal manometry, flexible sigmoidoscopy, and upper endoscopy, feeding a high-throughput workflow that supports early detection and streamlined referrals. Surgical services encompass bariatric procedures, cholecystectomy, colorectal surgery, inguinal hernia repair, and a growing array of laparoscopic gastrointestinal surgeries, while therapeutic offerings such as endoscopic mucosal resection, endoscopic submucosal dissection, hemorrhoid ligation, polypectomy, and sclerotherapy create pathways for definitive outpatient care that reduce inpatient demand.

Viewing the environment through the lens of indication highlights priorities in colorectal cancer screening, gastrointestinal infections, inflammatory bowel diseases, and liver cirrhosis, each requiring distinct diagnostic algorithms, peri-procedural risk stratification, and post-procedure follow-up. The level of care axis-observation versus same-day surgery-shapes staffing patterns, recovery room design, and scheduling practices to maximize throughput while preserving patient safety. Patient demographics also drive differential service models: pediatric cases demand age-appropriate sedation and family-centered workflows, adult pathways emphasize screening and chronic disease management, and geriatric populations require comorbidity-aware preoperative evaluation and enhanced recovery protocols.

Application-driven segmentation further clarifies resource allocation between diagnostic tests, endoscopy suites, and therapeutic interventions, influencing capital expenditure priorities and clinical competency development. End-user distinctions across clinics and physicians' offices, hospitals, and independent ASCs determine referral flows, case complexity, and negotiation leverage with payers and suppliers. Finally, ownership models-corporation-owned platforms, freestanding centers, and hospital-affiliated units-affect strategic orientation toward growth, scale, and integration; each structure brings trade-offs in capital access, operational autonomy, and the ability to standardize clinical protocols. Together, these segmentation lenses provide a comprehensive framework for aligning clinical services with financial strategy and patient needs.

Comparative regional dynamics and strategic considerations shaping adoption reimbursement and capacity building across Americas EMEA and Asia-Pacific

Regional dynamics substantially influence operational models, adoption curves for advanced procedures, and regulatory-compliance requirements across the globe. In the Americas, mature reimbursement infrastructures and a strong trend toward outpatient migration have driven rapid adoption of endoscopy-focused ASCs and independent surgical centers, with particular emphasis on colorectal cancer screening programs and efficiency-driven same-day surgery workflows. North American centers often leverage consolidated purchasing and established accreditation frameworks to standardize quality and drive down per-procedure costs, while market participants experiment with bundled-payment arrangements and partnerships with payer networks.

Across Europe, the Middle East, and Africa, heterogeneous reimbursement regimes and regulatory conditions create a mosaic of adoption rates. Western European systems frequently emphasize integrated care pathways and public-private collaboration, enabling hospital-affiliated ASCs to scale diagnostic and therapeutic endoscopy programs. In contrast, emerging markets within the region present opportunities for capacity-building, technology transfer, and targeted investments in high-impact services such as management of inflammatory bowel disease and gastrointestinal infection control. Regulatory variability also influences device registration timelines and cross-border procurement strategies.

The Asia-Pacific region demonstrates rapid uptake of minimally invasive and endoscopic therapeutic techniques, driven by rising demand for elective procedures, growing geriatric populations, and expanding private healthcare infrastructure. Local manufacturing footprints are strengthening in several countries, which can mitigate exposure to international trade disruptions and support competitive pricing. However, disparities in clinician training, reimbursement reform, and urban-rural access persist, requiring tailored strategies that combine workforce development, telehealth-enabled triage, and phased capital deployment to scale ambulatory gastroenterology capabilities effectively.

Competitive dynamics and partnership strategies among device makers ASC operators and integrated health systems driving innovation and operational scale

The competitive landscape for gastroenterology ambulatory services is defined by device manufacturers, technology innovators, ASC operators, and integrated health systems that pursue scale through clinical differentiation and partnerships. Device and consumable suppliers are prioritizing durability, image clarity, and disposable options that reduce cross-contamination risk while enabling cost-effective throughput. Vendors that couple hardware with analytics, remote monitoring, and service-level agreements provide ASC operators with tools to optimize uptime and procedural efficiency.

ASC operators and health systems are responding by forging alliances with technology partners, pursuing targeted acquisitions to expand geographic reach, and investing in center-of-excellence models that concentrate complex endoscopic procedures. Strategic purchasers are also focusing on vertical integration opportunities, such as combined ambulatory networks that include preoperative assessment platforms, centralized scheduling, and standardized clinical protocols to drive consistency and economies of scale. Emerging service models emphasize joint ventures between physician groups and corporate entities to balance clinical control with capital access. Across the ecosystem, the most successful organizations are those that balance clinical innovation with disciplined operational execution, leveraging supply-chain resilience, clinician engagement, and payer relationships to sustain growth and quality.

Actionable strategic directives for executive leaders to strengthen clinical capabilities diversify supply chains and capture value in ambulatory gastroenterology

Leaders in ambulatory gastroenterology should adopt a proactive, multi-dimensional strategy to capture clinical and economic value while mitigating downside risks. First, prioritize investment in diagnostic and therapeutic endoscopy capabilities that deliver high clinical yield and procedural efficiency, supported by structured training programs to scale clinician competency. Second, diversify procurement through multi-supplier contracts, regional manufacturing partnerships, and participation in cooperative purchasing arrangements to reduce exposure to supply-side shocks and tariff-related cost volatility. Third, refine service mix and throughput by expanding same-day surgery protocols, enhancing preoperative telehealth assessments, and optimizing observation pathways to reduce length of stay without compromising safety.

Additionally, pursue partnerships with payers and health systems to develop value-based arrangements for high-volume interventions such as colorectal cancer screening and chronic disease management programs, thereby aligning incentives for quality and cost control. Invest in digital infrastructure that integrates scheduling, perioperative documentation, and analytics to monitor outcomes and identify efficiency opportunities. For ownership groups, evaluate consolidation and joint-venture models to achieve the scale necessary for competitive procurement and capital access. Finally, emphasize patient experience and transparency to strengthen referral relationships and capture market share; clear communication about procedure expectations, recovery timelines, and cost can differentiate centers in increasingly consumer-driven care pathways.

A transparent mixed-methods research methodology combining primary interviews secondary evidence and scenario analysis to produce actionable ASC insights

The research underpinning this executive summary synthesizes primary and secondary investigative approaches to ensure rigor and relevance. Primary inputs included structured interviews with clinicians, ASC administrators, supply-chain professionals, and payers, providing qualitative insights into procedural workflows, procurement priorities, and reimbursement interactions. Secondary research encompassed peer-reviewed clinical literature, regulatory guidance, device performance documentation, and public filings to corroborate clinical trends and technological capabilities.

Analytical techniques employed triangulate qualitative observations with operational metrics such as throughput, case-mix complexity, and resource utilization to generate a coherent picture of current practice patterns. Segmentation analyses were conducted across services, indications, levels of care, patient demographics, applications, end-users, and ownership structures to surface differentiated strategies appropriate to each segment. Regional comparisons drew on policy analyses and adoption indicators to map readiness across the Americas, Europe, the Middle East and Africa, and Asia-Pacific. Where uncertainty exists-particularly around trade policy and reimbursement changes-scenario-based analysis was used to outline plausible operational responses and financial sensitivities. The methodology emphasizes transparency, reproducibility, and actionable insights tailored for strategic decision-making.

Concluding synthesis on why strategic alignment clinical investment and supply chain resilience determine long-term success for gastroenterology ASCs

Ambulatory gastroenterology centers sit at the intersection of clinical innovation, operational engineering, and changing consumer expectations, presenting both significant opportunities and clear execution challenges. Advances in diagnostic and therapeutic endoscopy, coupled with improvements in perioperative care, enable a broader set of procedures to transition to same-day and observation-based models, improving access and reducing total cost of care. However, external pressures including tariff volatility, supply-chain exposure, and uneven regional reimbursement frameworks require strategic responses that balance investment in clinical capability with disciplined operational and procurement practices.

Organizations that succeed will be those that align service portfolios with population needs, invest in clinician training and digital workflows, diversify supply chains to maintain resilience, and pursue partnership structures that provide capital and scale without sacrificing clinical autonomy. By focusing on value-measured through outcomes, patient experience, and total cost-providers can position ambulatory gastroenterology centers as a preferred site of care for a growing range of diagnostic and therapeutic interventions. Thoughtful execution, rigorous quality management, and adaptive strategy will determine which centers capitalize on the shift toward outpatient gastrointestinal care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastroenterology Ambulatory Surgery Center Market, by Services

  • 8.1. Diagnostic Services
    • 8.1.1. Capsule Endoscopy
    • 8.1.2. Colonoscopy
    • 8.1.3. Esophageal Manometry
    • 8.1.4. Flexible Sigmoidoscopy
    • 8.1.5. Upper Endoscopy
  • 8.2. Surgical Services
    • 8.2.1. Bariatric Surgery
    • 8.2.2. Cholecystectomy
    • 8.2.3. Colorectal Surgery
    • 8.2.4. Inguinal Hernia Repair
    • 8.2.5. Laparoscopic Gastrointestinal Surgeries
    • 8.2.6. Sphincterotomy
  • 8.3. Therapeutic Services
    • 8.3.1. Endoscopic Mucosal Resection
    • 8.3.2. Endoscopic Submucosal Dissection
    • 8.3.3. Hemorrhoid Ligation
    • 8.3.4. Polypectomy
    • 8.3.5. Sclerotherapy

9. Gastroenterology Ambulatory Surgery Center Market, by Indication

  • 9.1. Colorectal Cancer Screening
  • 9.2. Gastrointestinal Infections
  • 9.3. Inflammatory Bowel Diseases
  • 9.4. Liver Cirrhosis

10. Gastroenterology Ambulatory Surgery Center Market, by Level of Care

  • 10.1. Observation
  • 10.2. Same-Day Surgery

11. Gastroenterology Ambulatory Surgery Center Market, by Patient Demographic

  • 11.1. Adults
  • 11.2. Geriatric
  • 11.3. Pediatric

12. Gastroenterology Ambulatory Surgery Center Market, by Application

  • 12.1. Diagnostic Tests
  • 12.2. Endoscopy
  • 12.3. Therapeutic Interventions

13. Gastroenterology Ambulatory Surgery Center Market, by End-User

  • 13.1. Clinics & Physicians' Offices
  • 13.2. Hospitals
  • 13.3. Independent ASCs

14. Gastroenterology Ambulatory Surgery Center Market, by Ownership

  • 14.1. Corporation-Owned
  • 14.2. Freestanding
  • 14.3. Hospital-Affiliated

15. Gastroenterology Ambulatory Surgery Center Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Gastroenterology Ambulatory Surgery Center Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Gastroenterology Ambulatory Surgery Center Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Gastroenterology Ambulatory Surgery Center Market

19. China Gastroenterology Ambulatory Surgery Center Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Alabama Digestive Health Endoscopy Center (AL)
  • 20.6. Alfa Surgery Center, LLC
  • 20.7. Athens Gastroenterology Center
  • 20.8. Baptist Health South Florida, Inc.
  • 20.9. Covenant Physician Partners
  • 20.10. Envision Healthcare Corporation
  • 20.11. Gastro Health LLC
  • 20.12. Gastroenterology Associates Endoscopy Center
  • 20.13. GE HealthCare Technologies Inc.
  • 20.14. Gulf Coast Endoscopy Center
  • 20.15. HCA Healthcare, Inc.
  • 20.16. Inova McLean Ambulatory Surgery Center
  • 20.17. Jupiter Outpatient Surgery Center, LLC
  • 20.18. Liberty Endoscopy Center
  • 20.19. OHIO GASTROENTEROLOGY & LIVER INSTITUTE and GASTRO HEALTH
  • 20.20. Ohio Gastroenterology Group Inc.
  • 20.21. Ontario Advanced Surgery Center
  • 20.22. Regent Surgical
  • 20.23. SCA Health
  • 20.24. Shelby Ambulatory Surgery
  • 20.25. SOUTH BROWARD ENDOSCOPY, LLC
  • 20.26. Tenet Healthcare Corporation
  • 20.27. The Outpatient Center of Boynton Beach
  • 20.28. United Digestive
  • 20.29. Universal Health Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLONOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ESOPHAGEAL MANOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY UPPER ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY BARIATRIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CHOLECYSTECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INGUINAL HERNIA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LAPAROSCOPIC GASTROINTESTINAL SURGERIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SPHINCTEROTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC MUCOSAL RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPIC SUBMUCOSAL DISSECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HEMORRHOID LIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY POLYPECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SCLEROTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INFLAMMATORY BOWEL DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LIVER CIRRHOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OBSERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SAME-DAY SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC INTERVENTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CLINICS & PHYSICIANS' OFFICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDEPENDENT ASCS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY CORPORATION-OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 224. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 226. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 227. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 228. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 229. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 230. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 231. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 232. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 234. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 257. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 259. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 260. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 261. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 262. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 263. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 264. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMO